Ownership history in Point72 Asset Management, L.P. · 24 quarters on record
This page tracks every 13F SEC filing in which Point72 Asset Management, L.P. reported a position in ESPERION THERAPEUTICS INC NE (ESPR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 2,201 | -64,869 | -96.7% | 0.00% | $6K | $2.65 |
| 2024 Q2 | REDUCED | 67,070 | -192,930 | -74.2% | 0.00% | $149K | $2.22 |
| 2024 Q2 | ADDED | 260,000 | +243,930 | +1517.9% | 0.00% | $577K | $2.22 |
| 2024 Q1 | REDUCED | 16,070 | -183,930 | -92.0% | 0.00% | $43K | $2.68 |
| 2024 Q1 | ADDED | 200,000 | +195,200 | +4066.7% | 0.00% | $536K | $2.68 |
| 2023 Q4 | REDUCED | 4,800 | -3,093,052 | -99.8% | 0.00% | $14K | $2.99 |
| 2023 Q3 | REDUCED | 3,097,852 | -1,877,148 | -37.7% | 0.01% | $3.0M | $0.98 |
| 2023 Q2 | ADDED | 4,975,000 | +1,375,000 | +38.2% | 0.02% | $6.9M | $1.39 |
| 2023 Q1 | ADDED | 3,600,000 | +3,450,000 | +2300.0% | 0.02% | $5.7M | $1.59 |
| 2022 Q4 | REDUCED | 150,000 | -2,127,000 | -93.4% | 0.00% | $934K | $6.23 |
As of 2025 Q4 — sorted by position size